Patents in Indian Fisheries Sector  Patents in Indian Fisheries Sector  Living things generally do not qualify for being granted with patents.  If it.

Slides:



Advertisements
Similar presentations
Intellectual property rights and procurement = international developments & national experiences = Bi-regional Workshop on procurement and supply management.
Advertisements

1 WTO and medicines: from Doha to Cancún Germán Velásquez Essential Drugs and Medicines Policy World Health Organization Geneva, October 2003.
Actions Developing in Countries Accessing the WTO System Vung Tau, February 2006 “US – Brazil Compulsory licensing.
IP System and Economic Development: Empirical Evidence from China Qi Su IP Institute, Tong Ji University Dec 04, TongJi Global Intellectual Property.
RECOMMENDATIONS BY INTELLECTUAL PROPERTY LAWYERS ON LEGAL REFORM MOSES NKOMO LL.B, MIP.
China on the way to a high-technology country: The legal policy perspective Stefan Luginbuehl Lawyer, International Legal Affairs.
Possible Impact of Market Exclusivity Extension on Pharmaceuticals in Thailand Chutima Akaleephan International Health Policy Program, Thailand 27 August.
Intellectual Property Rights, Services and Trade Facilitation CARSTEN FINK African/LDCs Ambassadors Seminar on Post-Hong Kong Assessment of the Doha Round,
PRESENTED BY ELIZABETH TAMALE ASSISTANT COMMISSIONER MINISTRY OF TRADE, INDUSTRY AND COOPERATIVES AID FOR TRADE, INTELLECTUAL PROPERTY AND DEVELOPMENT-
1 Licensing Agreements and the Protection of Intellectual Property Chapter 17 © 2005 Thomson/West Legal Studies In Business.
1 Presented By: MP Bhatnagar New Delhi, India. 2 TRIPS Obligation and India (1) TRIPS Obligations & India’s Response Copyright: Article – 9,10,11,12,13,14.
IP News 指導老師:李柏靜 學生:黃馨葦 M /3/26.  Citing the high cost of one of the pharmaceutical industry's expensive new cancer drugs, India's patent.
1 ICC and AIPLA Paris, September 13, 2002 Felix Addor Chief Legal Officer and Deputy Director General Swiss Federal Institute of Intellectual Property.
1 Intellectual Property Rights in Medicines Procurement Patrick Osewe Senior HIV/AIDS Specialist World Bank.
A very short introduction to patents & access to medicines.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA AN OVERVIEW OF PATENT PROTECTION IN ZAMBIA.
Copyright © 2009 South-Western Legal Studies in Business, a part of South-Western Cengage Learning. CHAPTER 17 Licensing Agreements and the Protection.
Patent Related Flexibilities in the Pharmaceutical Field
Why is protecting pharmaceutical patents a controversial issue in DCs? Poor DCs can neither produce nor afford to buy patented drugs. They need generic.
IP Policy and its linkages with Economic, Science & Technology Policies Muhammad Ismail Deputy Director IPO-Pakistan October 09, 2013 IN THE NAME OF ALLAH,
TRIPS, Doha and Access to Medicines: Recent Lessons CARSTEN FINK Globalization, Intellectual Property Rights and Social Equity: Challenges and Opportunities.
PATENTS AND HEALTH. A CASE STUDY OF THE UGANDAN CONTEXT. (PHA3 JULY 7 TH 2012 –CAPE TOWN, SOUTH AFRICA) MS. MARIAM AKIROR LLB (HONS) / DIP. SW / CPC. PROG.
Colin McInnes Simon Rushton Owain Williams. From NHS to ‘Global Health’
Action against AIDS, Germany: Dr. Christiane Fischer MD PHD (presenter )(BUKO Pharma-Kampagne), Astrid Berner Rodoreda (Bread for the World) Igor Oliynyk.
Patents, TRIPS, Flexibilities & Access to Medicines –Legal Perspective Lesotho Civil Society Consultation Meeting 12 August 2014.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
 .
LESOTHO VALIDATION WORKSHOP 25 NOVEMBER 2014 CAILIN MORRISON RECAP – THE INTERNATIONAL CONTEXT: THE WTO, PATENTS, TRIPS FLEXIBILITIES & ACCESS TO MEDICINES.
WHO Perspective on Medicine Patents and FTAs Asian Regional Workshop on FTAs August, 2005, Kuala Lumpur, Malaysia Dr Zafar Mirza Regional Adviser,
1 CUTS International Capacity Building Training Programme on Advance IPR, WTO-Related Issues and Patent Writing April 28-May 02, 2008, Jaipur Session 10.
Intellectual Property Rights in the WTO CARSTEN FINK The WTO and the Doha Development Agenda Washington, DC, April 26, 2005.
EXCLUSIVE MARKETING RIGHTS & MAIL-BOX APPLICATIONS BY Manish Kumar Prusty T. Harish.
Ten Years of the Doha Declaration: The State of Implementation Geneva 14 November
Session 6 : An Introduction to the TRIPS Agreement UPOV, 1978 and 1991 and WIPO- Administered Treaties.
Page 1 Implementation of the WTO Decision on TRIPS and Public Health Government of Canada August 2004.
The Doha Declaration and the Protocol amending the TRIPS Agreement Islamabad, 28 November 2007 Octavio Espinosa WIPO.
O VERVIEW OF P UBLIC H EALTH -R ELATED TRIPS F LEXIBILITIES Sisule F. Musungu, IQsensato (
Intellectual Property Rights and Pharmaceuticals (Case study- Novartis’s claim in India) Background note prepared for PHM Vic Internet Workshop.
© 2008 International Intellectual Property June 24, 2009 Class 8 Patents: Multilateral Agreements (WTO TRIPS); Global Problem of Patent Protection for.
Presentation By Dr.S.N.Maity Controller General of Patents,Designs and TradeMarks.
UNCTAD/CD-TFT 1 IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade.
UNCTAD/CD-TFT 1 Basic Features of the Multilateral Systems of Patents and Regulatory Test Data Development Dimensions of Intellectual Property Rights Hanoi.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
A: Copy –Rights – Artistic, Literary work, Computer software Etc. B: Related Rights – Performers, Phonogram Producers, Broadcasters etc. C: Industrial.
Access to Medicines in Light of Patent Law Regime in India A LEGACY OF LEGISLATION OR LEASE OF THE JUDICIARY?
Agreement on TRIPS TRIPS Agreement  When the WTO was established, it led to 18 specific agreements to which all members need to adhere. Members necessarily.
Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies By Yvonne Nkrumah Legal Counsel, Ghana Food and Drugs Board.
No Incentive To Innovator Prior To 1st January 2005 Prior to 1st January 2005, the Indian Patent Act (1970) allowed only for process patents in all areas.
WTO and the TRIPS Agreement Wolf R. MEIER-EWERT WTO Secretariat A Business-oriented overview of Intellectual Property for Law Students WIPO, Geneva 20.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA RECAP ON PROCEEDINGS OF DAY 1 George Mpundu.
A presentation by Moses Nkomo Intellectual Property Attorney and Consultant National Workshop on TRIPS and access to medicines in Zimbabwe Holiday Inn,
Intellectual Property Law Introduction Victor H. Bouganim WCL, American University.
The Third Revision of the Chinese Patent Law State Intellectual Property Office of P.R.C Dec
The Inequals of Uruguay Srividhya Ragavan University of Oklahoma College of Law.
Overview: The South African IP Policy Review 13 September 2012 MacDonald Netshitenzhe: Chief Director- Policy and Legislation.
MGT601 SME MANAGEMENT. Lesson 39 Word Trade Organization (WTO.
NAFTA, CAFTA and Access to Medicines and Food Security in Latin America International Aids Conference Session “Globalization and FTAs: their impact, access.
Compulsory Licensing under Indian Patent Law. What is a patent A patent is a grant from the government which confers on the patentee for a limited period.
Overview of presentation
HISTORY OF IPR.
MGT601 SME MANAGEMENT.
WTO and medicines: from Doha to Cancún
Intellectual Property Protection and Access to Medicines
PATENTS, TRIPS, FLEXIBILITIES & ACCESS TO MEDICINES
WIPO NATIONAL SEMINAR ON INTELLECTUAL PROPERTY RIGHTS AND THE PROTECTION OF PHARMACEUTICAL PRODUCTS Damascus, April 25 and 26, 2005 Current issues on Intellectual.
Intellectual Property Rights: Practice and Process
IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade Agreements.
Intellectual Property Rights in Medicines Procurement
Presentation transcript:

Patents in Indian Fisheries Sector  Patents in Indian Fisheries Sector  Living things generally do not qualify for being granted with patents.  If it is altered by some means, say through biotechnological means, then they are considered, ‘new’ and “non-obvious things” and become patentable.  Fisheries sector could be protected with one or more intellectual Property Rights (IPRS) like breeders rights, patents, trademarks, geographic appellations, copy right, industrial designs, etc.

 Ninan and Sharma (2006) analysed the fisheries patents granted during the period 1913 to The salient features of this study are given below: *The number of patents granted in fisheries is relatively less *Patents for innovations in fisheries for Indian applicants is less than that of foreign applicants. *Aquaculture (31 patents) showed continuous granting of patent with one patent on an average per year for 87 years (1913 to 2000).

*Patenting in fish processing technology (83 patents) showed a steady increasing trend while in the case of fishing technology(37 patents) a declining trend was seen. *After the introduction of the Indian Patent Act 1970, about 3 patents per year on an average were granted. It rose to 6 per year in the post-WTO era ( ). *In the post-TRIPS era, the number of domestic applicants increased. *The study concluded that the “patent rights have not been exploited to the fullest extent in terms of enforcement and commercialization”.

Salient Features of Indian Patent (Amendment) Act  The Government of India brought out the Patents (Amendment) ordinance, 2004 to take care of issues relating to patent in the country. This ordinance was replaced by the Indian Patent (Amendent) Act,  India is under the obligation of introducing patent protection in food, chemicals and pharmacuaticals under the TRIPS agreement of the WTO with effect from  The new Act introduced some changes on the provisions of the Patents (Amendment)ordinance 2004 so as to address patent issues in the food, chemicals and pharmacauticals sectors.

Salient features of the Patents (Amendment) Bill 2005  The features in the Patents (Amendments) Bill, 2005 that are same as the provisions in the Patents (Amendment) Ordinance, 2004 are given below a)Extension of product patent protection to all fields of technology (i.e., drugs, foods and chemicals); b)Deletion of the provisions relating to Exclusive Marketing Rights(EMRs) (which would now become redundant), and introduction of a transitional provision for safeguarding EMRs already granted;

c) Introduction of a provision for enabling grant of compulsory licence for export of medicines to countries which have insufficient or no manufacturing capacity, to meet emergent public health situations (in accordance with the Doha Declaration on TRIPS and Public Health); d)Modification in the provisions relating to opposition procedures with a view to streamlining the system by having both Pre-grant and Post-grant opposition in the Patent Office;

e) Addition of a new proviso in respect of mailbox applications so that patent rights in respect of the mailbox shall be available only form the date of grant of patent, and not retrospectively from the date publication. f) Strengthening the provisions relating to national security to guard against patenting abroad of dual use technologies; g)Rationalisation of provisions relating to time-lines with a view to introducing flexibility and reducing the processing time for patent applications, and simplifying and rationalizing procedures.